PulseAugur
EN
LIVE 15:23:55
ENTITY TIGIT

TIGIT

PulseAugur coverage of TIGIT — every cluster mentioning TIGIT across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
0
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
1 over 90d
TIER MIX · 90D
TOPICS
RECENT · PAGE 1/1 · 2 TOTAL
  1. TOOL · CL_91619 ·

    Huayu Pharmaceutical's novel triple-target cancer therapy gains clinical trial approval

    Huayu Pharmaceutical's subsidiary, Huayu Haiyue, has received approval from China's National Medical Products Administration to begin clinical trials for HY07121, a novel subcutaneous injection for advanced solid tumors…

  2. COMMENTARY · CL_55224 ·

    TIGIT cancer drugs fail to replicate Keytruda's success

    The article discusses TIGIT drugs, a class of cancer immunotherapies that have largely failed to deliver on their initial promise. Similar to the disappointing amyloid-beta drugs for Alzheimer's, TIGIT drugs were develo…